REPORTS

Let’s Pullulate and Expand Your Business

Global Meningococcal Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 10, 2020  |  224 PAGES  |  REPORT CODE: CMM340373
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

The Meningococcal Vaccine is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period. The research provides insights for the global Meningococcal Vaccine market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Meningococcal Vaccine industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Meningococcal Vaccine Market Segmentations:

By Players:

  • Novartis

  • GSK

  • Merck

  • CSL

  • Baxter

  • JN International Medical Corporation

  • Serum Institute of India

  • Bio-Med

  • China National Biotec Group

  • Hualan Bio

  • Walvax

  • Zhifei

By Types:

  • Quadrivalent

  • Bivalent

  • Others

By End-User:

  • Pneumonia

  • Meningitis

  • Bacteremia

  • Others (Arthritis, Conjunctivitis, Urethritis)

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Meningococcal Vaccine Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Meningococcal Vaccine Market Size and Growth Rate of Quadrivalent from 2014 to 2026

    • 1.3.2 Global Meningococcal Vaccine Market Size and Growth Rate of Bivalent from 2014 to 2026

    • 1.3.3 Global Meningococcal Vaccine Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Meningococcal Vaccine Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • 1.4.2 Global Meningococcal Vaccine Market Size and Growth Rate of Meningitis from 2014 to 2026

    • 1.4.3 Global Meningococcal Vaccine Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • 1.4.4 Global Meningococcal Vaccine Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Meningococcal Vaccine Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Meningococcal Vaccine Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Meningococcal Vaccine by Major Types

    • 3.4.1 Meningococcal Vaccine Market Size and Growth Rate of Quadrivalent

    • 3.4.2 Meningococcal Vaccine Market Size and Growth Rate of Bivalent

    • 3.4.3 Meningococcal Vaccine Market Size and Growth Rate of Others

4 Segmentation of Meningococcal Vaccine Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Meningococcal Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Meningococcal Vaccine in Pneumonia

    • 4.4.2 Market Size and Growth Rate of Meningococcal Vaccine in Meningitis

    • 4.4.3 Market Size and Growth Rate of Meningococcal Vaccine in Bacteremia

    • 4.4.4 Market Size and Growth Rate of Meningococcal Vaccine in Others (Arthritis, Conjunctivitis, Urethritis)

5 Market Analysis by Major Regions

  • 5.1 Global Meningococcal Vaccine Production Analysis by Major Regions

  • 5.2 Global Meningococcal Vaccine Consumption Analysis by Major Regions

  • 5.3 Global Meningococcal Vaccine Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Meningococcal Vaccine Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Meningococcal Vaccine Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Meningococcal Vaccine Production, Import, Consumption and Export Analysis

6 Product Commodity of Meningococcal Vaccine Market in Major Countries

  • 6.1 Top 5 Export Countries in Meningococcal Vaccine market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Meningococcal Vaccine market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Meningococcal Vaccine market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Meningococcal Vaccine market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Meningococcal Vaccine market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Meningococcal Vaccine market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Meningococcal Vaccine Landscape Analysis

  • 7.1 North America Meningococcal Vaccine Landscape Analysis by Major Types

  • 7.2 North America Meningococcal Vaccine Landscape Analysis by Major End-Users

  • 7.3 North America Meningococcal Vaccine Landscape Analysis by Major Countries

    • 7.3.1 United States Meningococcal Vaccine Market Volume and Growth Rate

    • 7.3.2 Canada Meningococcal Vaccine Market Volume and Growth Rate

    • 7.3.3 Mexico Meningococcal Vaccine Market Volume and Growth Rate

8 Europe Meningococcal Vaccine Landscape Analysis

  • 8.1 Europe Meningococcal Vaccine Landscape Analysis by Major Types

  • 8.2 Europe Meningococcal Vaccine Landscape Analysis by Major End-Users

  • 8.3 Europe Meningococcal Vaccine Landscape Analysis by Major Countries

    • 8.3.1 Germany Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.2 UK Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.3 France Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.4 Italy Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.6 Spain Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.7 Belgium Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.8 Poland Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.9 Russia Meningococcal Vaccine Market Volume and Growth Rate

    • 8.3.10 Turkey Meningococcal Vaccine Market Volume and Growth Rate

9 Asia Pacific Meningococcal Vaccine Landscape Analysis

  • 9.1 Asia Pacific Meningococcal Vaccine Landscape Analysis by Major Types

  • 9.2 Asia Pacific Meningococcal Vaccine Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Meningococcal Vaccine Landscape Analysis by Major Countries

    • 9.3.1 China Meningococcal Vaccine Market Volume and Growth Rate

    • 9.3.2 Japan Meningococcal Vaccine Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Meningococcal Vaccine Market Volume and Growth Rate

    • 9.3.4 India Meningococcal Vaccine Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Meningococcal Vaccine Market Volume and Growth Rate

    • 9.3.6 South Korea Meningococcal Vaccine Market Volume and Growth Rate

10 Latin America, Middle East & Africa Meningococcal Vaccine Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Meningococcal Vaccine Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Meningococcal Vaccine Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Meningococcal Vaccine Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Meningococcal Vaccine Market Volume and Growth Rate

    • 10.3.2 Brazil Meningococcal Vaccine Market Volume and Growth Rate

    • 10.3.3 Nigeria Meningococcal Vaccine Market Volume and Growth Rate

    • 10.3.4 South Africa Meningococcal Vaccine Market Volume and Growth Rate 

    • 10.3.5 Argentina Meningococcal Vaccine Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Novartis

    • 11.1.1 Novartis Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 GSK

    • 11.2.1 GSK Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Merck

    • 11.3.1 Merck Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 CSL

    • 11.4.1 CSL Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Baxter

    • 11.5.1 Baxter Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 JN International Medical Corporation

    • 11.6.1 JN International Medical Corporation Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Serum Institute of India

    • 11.7.1 Serum Institute of India Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Bio-Med

    • 11.8.1 Bio-Med Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 China National Biotec Group

    • 11.9.1 China National Biotec Group Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Hualan Bio

    • 11.10.1 Hualan Bio Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Walvax

    • 11.11.1 Walvax Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Zhifei

    • 11.12.1 Zhifei Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 81 Figures and 200 Tables)

  • Figure Product Picture

  • Figure Meningococcal Vaccine Market Size and Growth Rate of Quadrivalent from 2014 to 2026

  • Figure Meningococcal Vaccine Market Size and Growth Rate of Bivalent from 2014 to 2026

  • Figure Meningococcal Vaccine Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Meningococcal Vaccine Market Size and Growth Rate of Pneumonia from 2014 to 2026

  • Figure Global Meningococcal Vaccine Market Size and Growth Rate of Meningitis from 2014 to 2026

  • Figure Global Meningococcal Vaccine Market Size and Growth Rate of Bacteremia from 2014 to 2026

  • Figure Global Meningococcal Vaccine Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Meningococcal Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Meningococcal Vaccine Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Meningococcal Vaccine

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Meningococcal Vaccine by Different Types from 2014 to 2026

  • Table Consumption Share of Meningococcal Vaccine by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Quadrivalent

  • Figure Market Size and Growth Rate of Bivalent

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Meningococcal Vaccine by Different End-Users from 2014 to 2026

  • Table Consumption Share of Meningococcal Vaccine by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Pneumonia

  • Figure Market Size and Growth Rate of Meningitis

  • Figure Market Size and Growth Rate of Bacteremia

  • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

  • Table Global Meningococcal Vaccine Production by Major Regions

  • Table Global Meningococcal Vaccine Production Share by Major Regions

  • Figure Global Meningococcal Vaccine Production Share by Major Regions in 2014

  • Figure Global Meningococcal Vaccine Production Share by Major Regions in 2018

  • Figure Global Meningococcal Vaccine Production Share by Major Regions in 2026

  • Table Global Meningococcal Vaccine Consumption by Major Regions

  • Table Global Meningococcal Vaccine Consumption Share by Major Regions

  • Figure Global Meningococcal Vaccine Consumption Share by Major Regions in 2014

  • Figure Global Meningococcal Vaccine Consumption Share by Major Regions in 2018

  • Figure Global Meningococcal Vaccine Consumption Share by Major Regions in 2026

  • Table North America Meningococcal Vaccine Production, Import, Consumption and Export Analysis

  • Table Europe Meningococcal Vaccine Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Meningococcal Vaccine Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Meningococcal Vaccine market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Meningococcal Vaccine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Meningococcal Vaccine market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Meningococcal Vaccine market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Meningococcal Vaccine Consumption by Types from 2014 to 2026

  • Table North America Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

  • Figure North America Meningococcal Vaccine Consumption Share by Types in 2014

  • Figure North America Meningococcal Vaccine Consumption Share by Types in 2018

  • Figure North America Meningococcal Vaccine Consumption Share by Types in 2026

  • Table North America Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

  • Table North America Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure North America Meningococcal Vaccine Consumption Share by End-Users in 2014

  • Figure North America Meningococcal Vaccine Consumption Share by End-Users in 2018

  • Figure North America Meningococcal Vaccine Consumption Share by End-Users in 2026

  • Table North America Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

  • Table North America Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Meningococcal Vaccine Consumption Share by Major Countries in 2014

  • Figure North America Meningococcal Vaccine Consumption Share by Major Countries in 2018

  • Figure North America Meningococcal Vaccine Consumption Share by Major Countries in 2026

  • Figure United States Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Meningococcal Vaccine Consumption by Types from 2014 to 2026

  • Table Europe Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Europe Meningococcal Vaccine Consumption Share by Types in 2014

  • Figure Europe Meningococcal Vaccine Consumption Share by Types in 2018

  • Figure Europe Meningococcal Vaccine Consumption Share by Types in 2026

  • Table Europe Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

  • Table Europe Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Meningococcal Vaccine Consumption Share by End-Users in 2014

  • Figure Europe Meningococcal Vaccine Consumption Share by End-Users in 2018

  • Figure Europe Meningococcal Vaccine Consumption Share by End-Users in 2026

  • Table Europe Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Europe Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Meningococcal Vaccine Consumption Share by Major Countries in 2014

  • Figure Europe Meningococcal Vaccine Consumption Share by Major Countries in 2018

  • Figure Europe Meningococcal Vaccine Consumption Share by Major Countries in 2026

  • Figure Germany Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure France Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Meningococcal Vaccine Consumption by Types from 2014 to 2026

  • Table Asia Pacific Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by Types in 2014

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by Types in 2018

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by Types in 2026

  • Table Asia Pacific Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by End-Users in 2014

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by End-Users in 2018

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by End-Users in 2026

  • Table Asia Pacific Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Meningococcal Vaccine Consumption Share by Major Countries in 2026

  • Figure China Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandMeningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure India Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Meningococcal Vaccine Consumption Share by Major Countries in 2026

  • Figure GCC Countries Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Meningococcal Vaccine Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of GSK

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

  • Figure Sales and Growth Rate Analysis of GSK

  • Figure Revenue and Market Share Analysis of GSK

  • Table Product and Service Introduction of GSK

  • Table Company Profile and Development Status of Merck

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

  • Figure Sales and Growth Rate Analysis of Merck

  • Figure Revenue and Market Share Analysis of Merck

  • Table Product and Service Introduction of Merck

  • Table Company Profile and Development Status of CSL

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

  • Figure Sales and Growth Rate Analysis of CSL

  • Figure Revenue and Market Share Analysis of CSL

  • Table Product and Service Introduction of CSL

  • Table Company Profile and Development Status of Baxter

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

  • Figure Sales and Growth Rate Analysis of Baxter

  • Figure Revenue and Market Share Analysis of Baxter

  • Table Product and Service Introduction of Baxter

  • Table Company Profile and Development Status of JN International Medical Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JN International Medical Corporation

  • Figure Sales and Growth Rate Analysis of JN International Medical Corporation

  • Figure Revenue and Market Share Analysis of JN International Medical Corporation

  • Table Product and Service Introduction of JN International Medical Corporation

  • Table Company Profile and Development Status of Serum Institute of India

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

  • Figure Sales and Growth Rate Analysis of Serum Institute of India

  • Figure Revenue and Market Share Analysis of Serum Institute of India

  • Table Product and Service Introduction of Serum Institute of India

  • Table Company Profile and Development Status of Bio-Med

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Med

  • Figure Sales and Growth Rate Analysis of Bio-Med

  • Figure Revenue and Market Share Analysis of Bio-Med

  • Table Product and Service Introduction of Bio-Med

  • Table Company Profile and Development Status of China National Biotec Group

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China National Biotec Group

  • Figure Sales and Growth Rate Analysis of China National Biotec Group

  • Figure Revenue and Market Share Analysis of China National Biotec Group

  • Table Product and Service Introduction of China National Biotec Group

  • Table Company Profile and Development Status of Hualan Bio

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio

  • Figure Sales and Growth Rate Analysis of Hualan Bio

  • Figure Revenue and Market Share Analysis of Hualan Bio

  • Table Product and Service Introduction of Hualan Bio

  • Table Company Profile and Development Status of Walvax

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Walvax

  • Figure Sales and Growth Rate Analysis of Walvax

  • Figure Revenue and Market Share Analysis of Walvax

  • Table Product and Service Introduction of Walvax

  • Table Company Profile and Development Status of Zhifei

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhifei

  • Figure Sales and Growth Rate Analysis of Zhifei

  • Figure Revenue and Market Share Analysis of Zhifei

  • Table Product and Service Introduction of Zhifei


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top